卵巢癌耐药机制与靶向治疗策略的研究进展
哈春芳， 李茹月 - 山东大学学报(医学版), 2021 - yxbwk.njournal.sdu.edu.cn
… treatment of Epithelial ovarian cancer(EOC). The application of no residual disease(R0)targeted
ovarian cancer … of drug resistance in ovarian cancer mainly include drug transport, drug …
ovarian cancer … of drug resistance in ovarian cancer mainly include drug transport, drug …
[PDF][PDF] 肿瘤酸性微环境的研究进展
周俊梅， 韦芳， 刘苗苗， 张必萌 - 现代生物医学进展, 2014 - biomed.cnjournals.com
… Tumor cell survival relies upon adaptation to the acidic … of autophagy gene Beclin 1 in
epithelial ovarian cancer [J]. Journal of … overcomes chemoresistance of breast cancer cells [J]. …
epithelial ovarian cancer [J]. Journal of … overcomes chemoresistance of breast cancer cells [J]. …
线粒体动力学调控肿瘤相关机制的研究进展
宁康浩， 闫聚瀚， 闫晓冬， 李佳程， 李向东 - 神经药理学报, 2024 - actanp.hebeinu.edu.cn
… 研 究发现在卵巢上皮癌(epithelial ovarian carcinoma, EOC) 中,Drp1 与负责有丝分裂的细胞
周期模块特异 性共表达,Drp1 可调节细胞周期促进有丝分裂,从 而支持肿瘤细胞的增殖等[31].在…
周期模块特异 性共表达,Drp1 可调节细胞周期促进有丝分裂,从 而支持肿瘤细胞的增殖等[31].在…
[HTML][HTML] 肿瘤细胞的糖代谢调控与肿瘤治疗
戈刘， 关斌宋 - Sheng Wu Yi Xue Gong Cheng Xue Za Zhi= Journal …, 2019 - ncbi.nlm.nih.gov
… Studies have shown that drugs that target tumor cell glucose metabolism have the ability
to selectively kill tumor cells, bringing new hope for tumor treatment. Tumor stem cells are …
to selectively kill tumor cells, bringing new hope for tumor treatment. Tumor stem cells are …
解读PGC-1α 在神经系统疾病中的作用: 从线粒体功能障碍到突触衰竭
JD Panes, A Wendt, O Ramirez-Molina… - 中国神经再生研究 …, 2022 - sjzsyj.com.cn
… It has been described that PGC-1α to reach maximal bioenergetics capacity, acts in association
with nuclear respiratory factors, such as nuclear respiratory factors 1 and 2 (NRF-1, NRF-…
with nuclear respiratory factors, such as nuclear respiratory factors 1 and 2 (NRF-1, NRF-…